Exercise Intolerance in Cirrhosis Patients: Research Reveals Key Findings

Strategic Insights -

Researchers at the University of Copenhagen conducted a study to explore the impact of cirrhosis on exercise intolerance in patients. The study involved eight patients with cirrhosis who underwent incremental cycling trials at different intensity levels, including light, moderate, and vigorous. The results showed that the patients experienced increased heart rate and accumulation of lactate and ammonia, which contributed to exercise intolerance.

Key Takeaways:

  • Cirrhosis patients experience compromised hepatocyte function and disturbed hepatic blood flow, leading to affected hepato-splanchnic substrate and metabolite fluxes.
  • Exercise intolerance in cirrhosis patients is exacerbated by the accumulation of lactate and ammonia.
  • Heart rate increases significantly during exercise in patients with cirrhosis, with values ranging from 68 to 140 beats/min.
  • The study involved eight cirrhotic patients who performed incremental cycling trials at light (28 [19-37] W), moderate (55 [41-69] W), and vigorous (76 [50-102] W) intensity.
  • The research was conducted by a team of researchers from the University of Copenhagen, led by Niels H. Secher.
  • The study's findings suggest that cirrhosis patients should avoid strenuous exercise to prevent exacerbating fatigue and intolerance.

Statistics:

  • The study involved 8 patients with cirrhosis who underwent incremental cycling trials.
  • The patients experienced a heart rate increase from 68 (62-74) at rest to 95 (90-100), 114 (108-120), and 140 (134-146) beats/min during exercise.
  • The patients accumulated lactate and ammonia during exercise, contributing to exercise intolerance.
  • The study was published in the journal Physiological Reports in 2024 (issue 12, volume 18).

Sources:

  • "Hepato-splanchnic fluxes during exercise in patients with cirrhosis-a pilot study." Physiological Reports, 2024;12(18).
  • NewsRx. University of Copenhagen Reports Findings in Cirrhosis (Hepato-splanchnic fluxes during exercise in patients with cirrhosis-a pilot study). Chemicals & Chemistry. October 11, 2024; p 6618.